Salvia
Divinorum Outlawed in Australia
An Update from the U.S. based Center for
Cognitive Liberty & Ethics, made possible by
the Salvia Divinorum Defense
Fund: http://www.alchemind.org/salvia_defense_fund.htm
Effective
June 1, Australia becomes the first country to make the plant Salvia
divinorum a prohibited drug. Pursuant to a ruling by Australia’s
National Drugs And Poisons Schedule Committee (NDPSC), both Salvia
divinorum and its active principle salvinorin A, will be added to
Schedule 9 of Australia’s Standard for the Uniform Scheduling of Drugs and
Poisons (SUSDP). Australia’s action raises fears that other governments
may soon follow suit.
Schedule
9 is Australia’s most restrictive drug schedule, and includes
“substances which may be abused or misused, the manufacture, possession,
sale or use of which should be prohibited by law except when required for
medical or scientific research, or for analytical, teaching or training
purposes with approval of Commonwealth and/or State or Territory Health
Authorities.”
Under
Australian law, drug control is a state rather than a federal issue. Thus
the NDPSC’s decision is technically only a recommendation to Australia’s
states and territories to prohibit both S. divinorum and salvinorin
A. It is practically unheard of, however, for states to deviate from the
NDPSC’s rulings. Accordingly it is a fait accompli that the possession,
distribution, or cultivation of S. divinorum and salvinorin A will
now be considered a criminal offense in all of Australia.
The
Alchemind Society’s Center for
Cognitive Liberty & Ethics has been in contact with a group of
scientific researchers in Australia who are working to challenge the
NDPSC’s ruling and block its adoption by the various states and
territories. So far these efforts have been unsuccessful.
Australia’s
scheduling of S. divinorum raises concerns that the US DEA, which is
known to be evaluating the plant for scheduling, may be spurred to prohibit
the plant as well. In anticipation of similar action by the DEA, the Center
for Cognitive Liberty & Ethics (CCLE) has established a SALVIA
DIVINORUM DEFENSE FUND for the purpose of raising the money necessary to
present a legal challenge to any scheduling move by the DEA. In October of
last year, a group of experts coordinated by the CCLE submitted a written
report to the US DEA, finding that Salvia divinorum does not meet the
criteria for inclusion in Schedule I of the US Controlled Substance Act.
Please
Make a Tax-deductable donation to the Salvia
Divinorum Defense Fund.
The CCLE
continues to monitor Salvia divinorum’s legal situation on a daily
basis. With your support, we will be able to mount a legal challenge to a
future scheduling move by the US DEA.
Donate online now
by visiting:
http://www.alchemind.org/salvia_defense_fund.htm
(Pay Pal accepted.)
Additional
Details about the Australian Scheduling Decision
The
NDPSC’s decision to place the S. divinorum and its active principle
into Schedule 9 – a schedule reserved for drugs with a “high potential
for abuse” and which present a “risk to public health and safety” –
appears to have no factual support.
At
its August 2001 meeting, The NDPSC considered scheduling S. divinorum,
noting that the plant was being “advertis[ed] for sale in Australia and
some broad based e-mail discussion groups on Australian web sites have
included discussion threads on Salvia
divinorum.”
Traditional
shamanic use of the plant was discounted by the NDPSC, which dismissively
commented, “There was no evidence of traditional therapeutic use other
than in shamanistic healing rituals.”
Finally,
while placement in Schedule 9 requires a finding that the plant or substance
presents a public health problem, the NDPSC made an end-run around this
important criterion, stating:
“The
Jurisdictions advised the Committee that they had not been advised that this
herb was causing public health problems, however this may simply reflect the
relative “newness” of the herb as a potential substance of abuse.”
The
NDPSC concluded its August 2001 meeting by noting: “there appear[s] to be
a prima facie case for control of Salvia
divinorum as an hallucinogen, but … there was no evidence of a major
public health hazard at this stage. Accordingly, the Committee agreed to
foreshadow appropriate Schedule 9 entries and seek public comment
At
its next meeting, held in November 2001, the NDPSC noted “there was no
response to the pre-meeting gazette notice in relation to the foreshadowed
decision to include Salvia Divinorum in
Schedule 9 of the SUSDP. However, a Minute was received from the Office of
Complementary Medicines of the TGA, thanking the Committee for considering
the inclusion of S. divinorum
into the SUSDP on public health and safety grounds.”
Yet,
with no more evidence than what existed (or didn’t exist) in August 2001,
the NDPSC then summarily ruled (Decision 2001/33-7) to include “Salvia
Divinorum in Schedule 9 of the SUSDP, on the basis of high potential for
abuse and risk to public health and safety.”
In
addition, the NDPSC included in Schedule 9
“8-METHOXYCARBONYL-4A,8A-DIMETHYL-6-ACETOXY-
5-KETO-3,4,4B,7,9,10,10A-SEPTAHYDRO-3-(4-FURANYL)- 2,1-NAPHTHO[4,3-E]PYRONE
*(SALVINORIN A).”
Help
Defend Salvia Divinorum Against A Similar Move By The DEA !
Make a Tax-Deductible Donation
to the Salvia
Divinorum Defense Fund!
http://www.alchemind.org/salvia_defense_fund.htm